Current Approaches to Systemic Management of Regionally Advanced or Metastatic Melanoma |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
Moving Forward in Multiple Myeloma |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
Dermatologic Toxicities Related to Cancer Immunotherapy |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 0.75 Pharmacology
|
Live |
10/15/2025 - 2:55pm PDT |
$0.00 |
Oncology 101: (On-Demand) - Nebraska Medicine - Ambulatory - Omaha and Kearney - 2026 |
- 17.75 AMA PRA Category 1 Credit™
- 17.75 ANCC
- 4.75 Pharmacology
|
Enduring |
|
$0.00 |
Oncology 102: (On-Demand) 2026 - Nebraska Medicine |
- 14.00 AMA PRA Category 1 Credit™
- 14.00 ANCC
- 2.25 Pharmacology
|
Enduring |
|
$0.00 |
From Data to Decisions: Appraising Clinical Trials for Real-World Practice |
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 0.25 Pharmacology
|
Enduring |
|
$0.00 |
From Slides to Strategy: Interpreting Pathology Reports for the Oncology APPs |
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 0.25 Pharmacology
|
Enduring |
|
$0.00 |